Belite Bio, Inc - BLTE

SEC FilingsOur BLTE Tweets

About Gravity Analytica

Recent News

  • 05.29.2025 - Benchmark's Healthcare House Call One-on-One Conference (Virtual)
  • 05.29.2025 - Benchmark's Healthcare House Call One-on-One Conference (Virtual)
  • 05.27.2025 - Stifel 2025 Ophthalmology Forum (Virtual)
  • 05.27.2025 - Stifel 2025 Ophthalmology Forum (Virtual)
  • 05.21.2025 - Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease
  • 05.21.2025 - Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease
  • 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ (New York, NY)
  • 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ (New York, NY)
  • 05.15.2025 - Deutsche Bank Depositary Receipts Virtual Investor Conference (Virtual)
  • 05.15.2025 - Deutsche Bank Depositary Receipts Virtual Investor Conference (Virtual)

Recent Filings

  • 05.21.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 05.21.2025 - 144 Report of proposed sale of securities
  • 05.21.2025 - EX-99.1 EX-99.1